We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
DAXsubsector Pharmaceuticals Kurs | DBI:I2PA | Deutsche Boerse Indices | Index |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
2.90 | 1.53% | 193.02 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
0 | 16:50:00 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
26 Apr 2024 | 193.02 | 2.90 | 1.53% | 193.02 | 193.02 | 0 |
25 Apr 2024 | 190.12 | -1.53 | -0.80% | 190.12 | 190.12 | 0 |
24 Apr 2024 | 191.65 | -2.24 | -1.16% | 191.65 | 191.65 | 0 |
23 Apr 2024 | 193.89 | 3.24 | 1.70% | 193.89 | 193.89 | 0 |
22 Apr 2024 | 190.65 | 4.87 | 2.62% | 190.65 | 190.65 | 0 |
19 Apr 2024 | 185.78 | -0.03 | -0.02% | 185.78 | 185.78 | 0 |
18 Apr 2024 | 185.81 | -0.30 | -0.16% | 185.81 | 185.81 | 0 |
17 Apr 2024 | 186.11 | -1.43 | -0.76% | 186.11 | 186.11 | 0 |
16 Apr 2024 | 187.54 | -2.15 | -1.13% | 187.54 | 187.54 | 0 |
15 Apr 2024 | 189.69 | -2.77 | -1.44% | 189.69 | 189.69 | 0 |
12 Apr 2024 | 192.46 | 0.69 | 0.36% | 192.46 | 192.46 | 0 |
11 Apr 2024 | 191.77 | -1.41 | -0.73% | 191.77 | 191.77 | 0 |
10 Apr 2024 | 193.18 | -0.99 | -0.51% | 193.18 | 193.18 | 0 |
09 Apr 2024 | 194.17 | 0.77 | 0.40% | 194.17 | 194.17 | 0 |
08 Apr 2024 | 193.40 | 0.00 | 0.00% | 193.40 | 193.40 | 0 |
05 Apr 2024 | 193.40 | -6.44 | -3.22% | 193.40 | 193.40 | 0 |
04 Apr 2024 | 199.84 | -1.77 | -0.88% | 199.84 | 199.84 | 0 |
03 Apr 2024 | 201.61 | 3.10 | 1.56% | 201.61 | 201.61 | 0 |
02 Apr 2024 | 198.51 | -4.94 | -2.43% | 198.51 | 198.51 | 0 |
28 Mar 2024 | 203.45 | 1.74 | 0.86% | 203.45 | 203.45 | 0 |
27 Mar 2024 | 201.71 | 4.97 | 2.53% | 201.71 | 201.71 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions